Recombinant Anti-CD28 x Anti-CD40 Bispecific Antibody (Triple Body) is designed to be expressed as three chains derived from the anti-CD28 antibody are both extended with the scFv fragment from an anti-CD40 antibody. This BsAb can increase T-cell proliferation, induce DC maturation and prime efficacy of cytotoxic T cells. It is designed for the research of Acute myeloid leukaemic (AML) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD28 x Anti-CD40 Bispecific Antibody (Triple Body) (TRIB-056). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS